Invention Grant
- Patent Title: Compositions and methods to treat cardiac diseases
- Patent Title (中): 治疗心脏病的组合物和方法
-
Application No.: US13031805Application Date: 2011-02-22
-
Publication No.: US08822434B2Publication Date: 2014-09-02
- Inventor: Bruce Liang , Kenneth A. Jacobson , Bhalchandra V. Joshi , Thatikonda Santhosh Kumar
- Applicant: Bruce Liang , Kenneth A. Jacobson , Bhalchandra V. Joshi , Thatikonda Santhosh Kumar
- Applicant Address: US CT Farmington US DC Washington
- Assignee: The University of Connecticut,The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee: The University of Connecticut,The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: US CT Farmington US DC Washington
- Agency: Cantor Colburn LLP
- Main IPC: A61K31/675
- IPC: A61K31/675 ; C07F9/6561

Abstract:
Phosphonate and phosphinate N-methanocarba derivatives of AMP including their prodrug analogs are described. MRS2339, a 2-chloro-AMP derivative containing a (N)-methanocarba (bicyclo[3.1.0]hexane) ring system in place of ribose, activates P2X receptors, ligand-gated ion channels. Phosphonate analogs of MRS2339 were synthesized using Michaelis-Arbuzov and Wittig reactions, based on the expectation of increased half-life in vivo due to the stability of the C—P bond. When administered to calsequestrin-overexpressing mice (a genetic model of heart failure) via a mini-osmotic pump (Alzet), some analogs significantly increased intact heart contractile function in vivo, as assessed by echocardiography-derived fractional shortening (FS) as compared to vehicle-infused mice. The range of carbocyclic nucleotide analogs for treatment of heart failure has been expanded.
Public/Granted literature
- US20110212924A1 COMPOSITIONS AND METHODS TO TREAT CARDIAC DISEASES Public/Granted day:2011-09-01
Information query